Does NILOTINIB Cause Aplastic anaemia? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Aplastic anaemia have been filed in association with NILOTINIB (nilotinib). This represents 0.1% of all adverse event reports for NILOTINIB.
16
Reports of Aplastic anaemia with NILOTINIB
0.1%
of all NILOTINIB reports
4
Deaths
5
Hospitalizations
How Dangerous Is Aplastic anaemia From NILOTINIB?
Of the 16 reports, 4 (25.0%) resulted in death, 5 (31.3%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Aplastic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NILOTINIB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does NILOTINIB Cause?
Death (2,667)
Fatigue (1,679)
Rash (1,250)
Nausea (1,180)
Headache (1,177)
Pain (1,169)
Dyspnoea (1,070)
Diarrhoea (998)
Drug ineffective (992)
Malaise (961)
What Other Drugs Cause Aplastic anaemia?
ECULIZUMAB (345)
CYCLOPHOSPHAMIDE (332)
CYCLOSPORINE (331)
METHOTREXATE (281)
BUSULFAN (220)
FLUDARABINE (220)
ETOPOSIDE (186)
VINCRISTINE (173)
CYTARABINE (163)
ELTROMBOPAG OLAMINE (149)
Which NILOTINIB Alternatives Have Lower Aplastic anaemia Risk?
NILOTINIB vs NIMESULIDE
NILOTINIB vs NIMODIPINE
NILOTINIB vs NINTEDANIB
NILOTINIB vs NINTEDANIB ESYLATE
NILOTINIB vs NIRAPARIB